• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

August 8, 2016

Trending News Today: Opdivo Fails in Lung Cancer Trial

Author(s):

Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

Starting in 2018, high-income Americans covered by Medicare will have an increase in premium surcharges, and now is the time to make tax moves in order to help minimize these surcharges, reported The Wall Street Journal. The increase is based on a decision by Congress that the top 5% of Medicare recipients should contribute more for their coverage than lower earners. However, through careful planning, premiums can often be reduced, and the following key moves could help lessen the blow: revamp charitable contributions; look into shifting assets from a traditional IRA into a Roth IRA; manage capital gains and losses; time the receipt of income; and turn to work-related savings.

The pharmaceutical field was met with a surprise on Friday, when Bristol-Myers Squibb most popular selling drug Opdivo failed in a clinical trial as an initial treatment of expanded use for lung cancer. According to The New York Times, Opdivo failed to slow the progression of advanced lung cancer. This failure will most likely result in a significant drop in overall sales, with shares of Bristol-Myers already plummeting 17% in afternoon trading. “This is a major surprise — possibly the biggest clinical surprise of my career,” Dr. Mark Schoenebaum, a pharmaceutical analyst at Evercore ISI, told the Times. Timothy Anderson, an analyst at Sanford C. Bernstein & Company believes that Bristol-Myers may have “pushed the envelope too far in designing its trial” by hoping to broaden the population eligible for treatment and setting the cutoff value for PD-L1 levels too low.

Findings from a new study revealed that black men who undergo treatment for prostate cancer with hormone therapy may have a higher risk of death than white men, reported The Washington Post. Although black men in the study had a higher incidence of death after only 4 months of hormone therapy, none of the deaths were actually caused by prostate cancer, but instead appeared to be related to cardiovascular health issues that were present prior to their cancer diagnosis. Lead researcher Konstantin Kovtun, noted that African American men have an onset of cardiovascular issues that are linked to ADT use. “If I was a physician and I had the data now available for the study, I would be more careful in using ADT for African American men,” Kovtun said in the report.

Related Videos
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Newborn baby -- Image credit: kieferpix | stock.adobe.com
May 8th 2025

INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC

Gillian McGovern, Associate Editor
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
AI image of child with brain tumor | Image Credit: © Lila Patel - stock.adobe.com
May 6th 2025

Investigational CAR T-Cell Therapy BCB-276 Receives FDA Breakthrough Designation for Pediatric Patients With DIPG

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Liver with fibrosis -- Image credit: Rasi | stock.adobe.com
May 6th 2025

Study Demonstrates Semaglutide Improves Liver Histologic Results in Patients With MASH

Gillian McGovern, Associate Editor
Psilocybin at the Crossroads: Regulatory Barriers and the Pharmacist’s Role in Palliative Innovation
May 6th 2025

Psilocybin at the Crossroads: Regulatory Barriers and the Pharmacist’s Role in Palliative Innovation

Abigail Thomas, PharmD Lee A. Kral, PharmD Alana Hippensteele, Lead Editor
Related Content
Advertisement
Newborn baby -- Image credit: kieferpix | stock.adobe.com
May 8th 2025

INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC

Gillian McGovern, Associate Editor
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
AI image of child with brain tumor | Image Credit: © Lila Patel - stock.adobe.com
May 6th 2025

Investigational CAR T-Cell Therapy BCB-276 Receives FDA Breakthrough Designation for Pediatric Patients With DIPG

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Liver with fibrosis -- Image credit: Rasi | stock.adobe.com
May 6th 2025

Study Demonstrates Semaglutide Improves Liver Histologic Results in Patients With MASH

Gillian McGovern, Associate Editor
Psilocybin at the Crossroads: Regulatory Barriers and the Pharmacist’s Role in Palliative Innovation
May 6th 2025

Psilocybin at the Crossroads: Regulatory Barriers and the Pharmacist’s Role in Palliative Innovation

Abigail Thomas, PharmD Lee A. Kral, PharmD Alana Hippensteele, Lead Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.